Intangible assets, net

3 Months Ended

Mar. 31, 2017

Intangible assets, net [Abstract]

Intangible assets, net

7. Intangible assets, net

At March 31, 2017 and December 31, 2016, intangible assets, primarily consisting of acquired patents, and accumulated amortization were as follows (in thousands):

	March 31, 2017 (unaudited) (1)			December 31, 2016
Intangible assets	$	23,294		$	25,703
Accumulated amortization		(14,648	)		(15,497	)
Intangible assets, net	$	8,646		$	10,206

⁽¹⁾ Reflects the effect of the OncoCyte Deconsolidation.

BioTime recognized $602,000 and $1.3 million in amortization expense of intangible assets, included in research and development expenses, during the three months ended March 31, 2017 and 2016, respectively.